International Biotechnology Trust PLC Allogene Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

  • $295 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
BUY
$10.32 - $17.28 $510,117 - $854,150
49,430 Added 8671.93%
50,000 $539,000
Q2 2022

Aug 16, 2022
SELL
$6.78 - $12.28 $335,135 - $607,000
-49,430 Reduced 98.86%
570 $50 Million
Q4 2021

Feb 15, 2022
BUY
$13.13 - $24.52 $656,500 - $1.23 Million
50,000 New
50,000 $747,000

Others Institutions Holding ALLO

# of Institutions
165
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $279M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email